½ÃÀ庸°í¼­
»óǰÄÚµå
1592115

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå : °Ë»ç, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Legionella Testing Market by Test (Culture Methods, Direct Fluorescent Antibody Test, Nucleic Acid-Based Detection), Application (Clinical Testing Methods, Environmental Testing Methods), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº 2023³â¿¡ 3¾ï 5,437¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 3¾ï 8,586¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.97%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 6¾ï 4,696¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

·¹Áö¿À³Ú¶ó±Õ °Ë»ç´Â ½É°¢ÇÑ Æó·ÅÀÎ ·¹Áö¿À³Ú¶óÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ·¹Áö¿À³Ú¶ó±ÕÀÇ °ËÃâ ¹× Á¤·®È­¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ °Ë»ç´Â º´¿ø, È£ÅÚ, »ê¾÷ ½Ã¼³, ÁÖÅà µî ´Ù¾çÇÑ È¯°æ¿¡¼­ ¹°ÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ·¹Áö¿À³Ú¶ó±Õ °Ë»çÀÇ Çʿ伺Àº ±ÔÁ¦ Àǹ« Áõ°¡, ¼öÀμº Àü¿°º´¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, °øÁß º¸°Ç ¹× ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á Áõ°¡·Î ÀÎÇØ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÁÖ·Î ÀÏ»óÀûÀÎ °¨½Ã, ¹ßº´ Á¶»ç, Áúº´ ¹ß»ýÀ» ¿¹¹æÇϱâ À§ÇÑ À§Çè Æò°¡ µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµË´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ´Â ÀÇ·á, ¼­ºñ½º¾÷, Á¦Á¶¾÷, Á¤ºÎ ±â°ü µî ´Ù¾çÇÑ ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ½Å¼Ó PCR ±â¹Ý ºÐ¼®¹ýÀ̳ª »õ·Î¿î ¸é¿ª ºÐ¼®¹ý µî °Ë»ç¹ýÀÇ ±â¼ú ¹ßÀü, ¾ö°ÝÇÑ ¼öÁú °ü¸®¸¦ ¿ä±¸ÇÏ´Â ÀÎÇÁ¶ó ±¸ÃàÀÇ ÁøÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ÀÇ ±âȸ°¡ ÀÖ´Â °÷Àº ÀÎÇÁ¶ó°¡ Àß ±¸ÃàµÇ¾î ÀÖ°í, ±ÔÁ¦ ü°è°¡ ¾ö°ÝÇÑ ½ÅÈï °æÁ¦ ±¹°¡µéÀÔ´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ÀÎÁöµµ¸¦ ³ôÀÌ°í º¸±ÞÀ» ÃËÁøÇϱâ À§ÇÑ Áö¹æ Á¤ºÎ ±â°ü°úÀÇ ÆÄÆ®³Ê½ÊÀº ½ÃÀå ÁøÀÔÀ» ´õ¿í È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü °Ë»ç ¹æ¹ý¿¡ µû¸¥ ³ôÀº ºñ¿ë, Áö¿ªº°·Î »óÀÌÇÑ ±ÔÁ¦, °¨Áö ±â¼ú Ç¥ÁØÈ­ ¹®Á¦ µîÀº ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀÇ ±âȸ´Â ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î °Ë»ç ŰƮ °³¹ß, IoT¸¦ Ȱ¿ëÇÑ ½Ç½Ã°£ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ °³¹ß, ¿À¿° Á¦°Å¸¦ À§ÇÑ ÀáÀçÀû »ý¹°ÇÐÀû Á¦Á¦ Ž»ö¿¡ ÀÖ½À´Ï´Ù. ¿¬±¸´Â °Ë»ç ¹Î°¨µµ¿Í ƯÀ̵µ Çâ»ó, ¹° ½Ã½ºÅÛ °ü¸®¿¡¼­ ¿¹Ãø ºÐ¼®À» À§ÇÑ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ¼ºÀåÇϰí ÀÖÀ¸¸ç, ±× Ãß¼¼´Â ¸¹Àº ¼öÁú ¹®Á¦¸¦ ÇØ°áÇÏ´Â º¸´Ù Á¾ÇÕÀûÀ̰í ÅëÇÕµÈ ¼Ö·ç¼ÇÀ¸·Î ±â¿ï¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚµéÀº ÃÖÁ¾»ç¿ëÀÚ¿Í ±ÔÁ¦±â°üÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¸¦ ÃæÁ·Çϴ ȹ±âÀûÀÎ Á¦Ç°À» µµÀÔÇϱâ À§ÇØ Àü·«Àû Çù·Â°ú ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¿ì¼±¼øÀ§¿¡ µÎ¾î ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 3¾ï 5,437¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 3¾ï 8,586¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 6¾ï 4,696¸¸ ´Þ·¯
CAGR(%) 8.97%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ·¹Áö¿À³Ú¶ó °ü·Ã Áúº´ÀÇ ¹ß»ý·ü Áõ°¡
    • ¸¹Àº »ê¾÷¿¡¼­ ¼öÁú °Ë»ç Ȱµ¿ÀÇ Á߿伺 Áõ°¡
    • Àú¼öÁö ¸ð´ÏÅ͸µ¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Áø´Ü°Ë»çÀÇ ¹Î°¨µµ ¹®Á¦
    • °Ë»ç¿¡ µû¸¥ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ·¹Áö¿À³Ú¶ó±Õ °Ë»çÀÇ ±â¼ú ¹ßÀü
    • ÀÚ°¡ °Ë»ç ŰƮÀÇ ÃâÇö
  • ½ÃÀå °úÁ¦
    • ÃæºÐÇÑ Áø´Ü ÀÎÇÁ¶ó ºÎÁ·

Porter's Five Forces: ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå °ø·«À» À§ÇÑ Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, À̸¦ ÅëÇØ °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå : °Ë»çº°

  • ¼­·Ð
  • ¹è¾ç ¹æ¹ý
  • Á÷Á¢ Çü±¤ Ç×ü °Ë»ç
  • ÇÙ»ê ±â¹Ý ŽÁö
  • Ç÷ûÇÐ
  • ´¢Áß Ç׿ø °Ë»ç

Á¦7Àå ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå : ¿ëµµº°

  • ¼­·Ð
  • ÀÓ»ó °Ë»ç
  • ȯ°æ °Ë»ç

Á¦8Àå ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • Áø´Ü ½ÇÇè½Ç
  • º´¿ø¡¤Å¬¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Albagaia Ltd.
  • Alere, Inc.
  • Aquacert Ltd.
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • bioMerieux SA
  • Eiken Chemical Co., Ltd
  • Hologic, Inc.
  • IDEXX Laboratories, Inc.
  • Merck KGaA
  • PACIFIC WATER TECHNOLOGY PTY LTD
  • Phigenics LLC
  • Thermo Fisher Scientific, Inc.
KSA 24.11.27

The Legionella Testing Market was valued at USD 354.37 million in 2023, expected to reach USD 385.86 million in 2024, and is projected to grow at a CAGR of 8.97%, to USD 646.96 million by 2030.

Legionella testing involves the detection and quantification of Legionella bacteria, which can cause Legionnaires' disease, a severe form of pneumonia. The testing is essential for ensuring water safety in various settings such as hospitals, hotels, industrial facilities, and residential buildings. The necessity of Legionella testing has been underscored by increasing regulatory mandates, growing awareness of waterborne diseases, and rising concerns regarding public health and safety. Applications primarily involve routine surveillance, outbreak investigations, and risk assessments to prevent disease outbreaks. End-users span across healthcare, hospitality, manufacturing, and government sectors. Key growth factors for the Legionella testing market include technological advancements in testing methods, like rapid PCR-based assays and novel immunoassays, as well as increased infrastructure development that demands rigorous water quality management. Market opportunities lie in emerging economies where infrastructure development is robust, coupled with regulatory frameworks becoming more stringent. Partnerships with local governing bodies to promote awareness and the deployment of remote monitoring solutions can further expand market reach. However, limitations include high costs associated with advanced testing methods, regulatory variations across regions, and issues with the standardization of detection techniques that could hinder market expansion. Innovation opportunities exist in developing cost-effective and easy-to-use test kits, real-time monitoring systems using IoT, and exploring potential biologics for decontamination. Research efforts can focus on improving test sensitivity and specificity, as well as the integration of AI and machine learning for predictive analytics in water systems management. The Legionella testing market is competitive and growing, with the trend tilting towards more comprehensive, integrated solutions that address a multitude of water quality issues. Stakeholders should prioritize strategic collaborations and investment in R&D to introduce groundbreaking products that meet the evolving needs of end-users and regulatory bodies, thereby facilitating sustainable growth in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 354.37 million
Estimated Year [2024] USD 385.86 million
Forecast Year [2030] USD 646.96 million
CAGR (%) 8.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Legionella Testing Market

The Legionella Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of legionella-related disorders
    • Rising importance of water testing activities in many industries
    • Stringent regulations for monitoring water reservoirs
  • Market Restraints
    • Issues in sensitivity of diagnostic tests
    • High cost associated with the test
  • Market Opportunities
    • Technological advancement in legionella testing
    • Emergence of self-testing kits
  • Market Challenges
    • Lack of sufficient diagnostic infrastructure

Porter's Five Forces: A Strategic Tool for Navigating the Legionella Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Legionella Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Legionella Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Legionella Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Legionella Testing Market

A detailed market share analysis in the Legionella Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Legionella Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Legionella Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Legionella Testing Market

A strategic analysis of the Legionella Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Legionella Testing Market, highlighting leading vendors and their innovative profiles. These include Albagaia Ltd., Alere, Inc., Aquacert Ltd., Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, bioMerieux SA, Eiken Chemical Co., Ltd, Hologic, Inc., IDEXX Laboratories, Inc., Merck KGaA, PACIFIC WATER TECHNOLOGY PTY LTD, Phigenics LLC, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Legionella Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Culture Methods, Direct Fluorescent Antibody Test, Nucleic Acid-Based Detection, Serology, and Urinary Antigen Test.
  • Based on Application, market is studied across Clinical Testing Methods and Environmental Testing Methods.
  • Based on End-User, market is studied across Diagnostic Laboratories and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of legionella-related disorders
      • 5.1.1.2. Rising importance of water testing activities in many industries
      • 5.1.1.3. Stringent regulations for monitoring water reservoirs
    • 5.1.2. Restraints
      • 5.1.2.1. Issues in sensitivity of diagnostic tests
      • 5.1.2.2. High cost associated with the test
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in legionella testing
      • 5.1.3.2. Emergence of self-testing kits
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of sufficient diagnostic infrastructure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Legionella Testing Market, by Test

  • 6.1. Introduction
  • 6.2. Culture Methods
  • 6.3. Direct Fluorescent Antibody Test
  • 6.4. Nucleic Acid-Based Detection
  • 6.5. Serology
  • 6.6. Urinary Antigen Test

7. Legionella Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Testing Methods
  • 7.3. Environmental Testing Methods

8. Legionella Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Clinics

9. Americas Legionella Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Legionella Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Legionella Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Albagaia Ltd.
  • 2. Alere, Inc.
  • 3. Aquacert Ltd.
  • 4. Beckman Coulter, Inc.
  • 5. Becton, Dickinson, and Company
  • 6. Bio-Rad Laboratories, Inc
  • 7. bioMerieux SA
  • 8. Eiken Chemical Co., Ltd
  • 9. Hologic, Inc.
  • 10. IDEXX Laboratories, Inc.
  • 11. Merck KGaA
  • 12. PACIFIC WATER TECHNOLOGY PTY LTD
  • 13. Phigenics LLC
  • 14. Thermo Fisher Scientific, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦